Fatigue that gets progressively worse despite following management strategies suggests an underlying cause that needs investigation
Being initially used for the management of T2DM, GLP-1 medications use semaglutide, liraglutide, dulaglutide, or tirzepatide, marketed under the brand names of Ozempic, Victoza, Trulicity, and Mounjaro, respectively
The pentadecapeptide plays a key role in promoting angiogenesis by stimulating new blood vessel growth
If its for general wellness or appearance, its not eligible
At present, several oral antidiabetic medications are used for the treatment of T2DM including, -glucosidases inhibitors, biguanides, sulfonylureas, meglitinides, GLP-1 receptor agonists (GLP-1RAs), peroxisome proliferator-activated receptor (PPAR-) agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and sodiumglucose transporter 2 (SGLT2) inhibitors